1. Home
  2. MPB vs IMMX Comparison

MPB vs IMMX Comparison

Compare MPB & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$35.27

Market Cap

827.5M

Sector

Finance

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$9.57

Market Cap

716.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
IMMX
Founded
1868
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.5M
716.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
MPB
IMMX
Price
$35.27
$9.57
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$37.00
$19.20
AVG Volume (30 Days)
196.5K
2.3M
Earning Date
04-21-2026
05-08-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
$30.95
N/A
Revenue Next Year
$9.45
N/A
P/E Ratio
$97.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.50
$1.94
52 Week High
$37.18
$12.14

Technical Indicators

Market Signals
Indicator
MPB
IMMX
Relative Strength Index (RSI) 56.81 47.11
Support Level $30.82 $7.99
Resistance Level $35.98 $10.61
Average True Range (ATR) 0.81 0.94
MACD 0.01 -0.20
Stochastic Oscillator 43.22 26.80

Price Performance

Historical Comparison
MPB
IMMX

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: